Insider transactions

EDGAR

HEARTBEAM, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
9 transactions, 1,188,750 shares
Sum of shares × price per share: 951,000
Open-market sales (code S)
3 transactions, 307,146 shares
Sum of shares × price per share: 1,077,090.03

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–39 of 39

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-02 Filed 2026-10-09Ferrari Richard Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (125,000)
Acquired (A)125,0000—125,000Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • F2 The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the Plan), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.
Open filing 0001213900-26-108490 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09Ferrari Richard Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (90,625)
Acquired (A)90,6250—90,625Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • F3 Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date.
Open filing 0001213900-26-108490 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09Ferrari Richard Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (125,000) — exercise price 0.435
Acquired (A)125,0000—125,000Direct (D) No
F4
  • F4 Represents a nonqualified stock option granted to the Reporting Person on October 2, 2026 under the Plan in connection with the Reporting Person's additional responsibilities as Chair of the Board. One-twelfth of the shares subject to the option vest on each monthly anniversary of July 1, 2026, such that 3/12ths of the shares subject to the option were vested on the grant date and the option will be fully vested on July 1, 2027, subject to the Reporting Person's continued service as a director through each vesting date.
Open filing 0001213900-26-108490 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09de Urioste George Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (93,750)
Acquired (A)93,7500—93,750Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock upon settlement.
  • F2 The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the Plan), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.
Open filing 0001213900-26-108486 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09de Urioste George Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (93,750) — exercise price 0.435
Acquired (A)93,7500—93,750Direct (D) No
F3
  • F3 The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan).
Open filing 0001213900-26-108486 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09Nelson Kenneth Warwick III Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (93,750)
Acquired (A)93,7500—93,750Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock upon settlement.
  • F2 The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the Plan), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.
Open filing 0001213900-26-108487 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09Nelson Kenneth Warwick III Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (31,250)
Acquired (A)31,2500—31,250Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock upon settlement.
  • F3 Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date.
Open filing 0001213900-26-108487 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09JAFF MICHAEL R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (93,750)
Acquired (A)93,7500—93,750Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • F2 The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the Plan), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.
Open filing 0001213900-26-108489 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09JAFF MICHAEL R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (37,500)
Acquired (A)37,5000—37,500Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • F3 Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date.
Open filing 0001213900-26-108489 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09Elfrink Willem Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (93,750)
Acquired (A)93,7500—93,750Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • F2 The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the Plan), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.
Open filing 0001213900-26-108491 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09Elfrink Willem Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (93,750) — exercise price 0.435
Acquired (A)93,7500—93,750Direct (D) No
F3
  • F3 The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan).
Open filing 0001213900-26-108491 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09Ortigas-Wedekind Marga Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (93,750)
Acquired (A)93,7500—93,750Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • F2 The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the Plan), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.
Open filing 0001213900-26-108488 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-09Ortigas-Wedekind Marga Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (81,250) — exercise price 0.435
Acquired (A)81,2500—81,250Direct (D) No
F3
  • F3 The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan).
Open filing 0001213900-26-108488 Read from the filing’s XML Dispute this row
2026-07-24 Filed 2026-07-24Persen Kenneth Harry Officer: Chief Technology Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)105,7400—448,290Direct (D) No
F1
  • F1 Represents Restricted Stock Units (RSUs) granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash.
Open filing 0001213900-26-081458 Read from the filing’s XML Dispute this row
2026-07-24 Filed 2026-07-24Cruickshank Tim Officer: CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)167,7600—239,990Direct (D) No
F1
  • F1 Represents Restricted Stock Units (RSUs) granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash.
Open filing 0001213900-26-081455 Read from the filing’s XML Dispute this row
2026-07-24 Filed 2026-07-24Vajdic Branislav Director · Officer: President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)260,8700—3,970,784Direct (D) No
F2
  • F2 Represents Restricted Stock Units (RSUs) granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash.
Open filing 0001213900-26-081450 Read from the filing’s XML Dispute this row
2026-06-15 Filed 2026-07-24Vajdic Branislav Director · Officer: President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,800,0000—3,709,914Direct (D) No
F1
  • F1 Represents the grant of 2,800,000 performance-based restricted stock units (PRSUs) under the HeartBeam, Inc. 2022 Equity Incentive Plan on June 15, 2026. The PRSUs are subject to performance-based milestones and service-based vesting conditions over a three-year period. Each PRSU represents a contingent right to receive one share of Common Stock upon vesting.
Open filing 0001213900-26-081450 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-24Ferrari Richard Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)57,5000.8
46,000

Derived: shares × price per share. Exact value 46000.0.

286,636Direct (D) No
F1
  • F1 These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. This amendment restates the Reporting Person's original Form 4 filed on April 16, 2026, solely to correct an inadvertent error in the number of shares of common stock reported as acquired and the corresponding total beneficial ownership. The original filing reported the acquisition of 62,500 shares of common stock. The correct number of shares acquired was 57,500 shares of common stock. No other changes have been made to the original filing.
Open filing 0001213900-26-047514 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-16JAFF MICHAEL R Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)31,2500.80
25,000

Derived: shares × price per share. Exact value 25000.00.

31,250Indirect (I) See FootnoteNo
F1, F2
  • F1 These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.
  • F2 The shares are indirectly held by the Reporting Person under the entity Open Book Healthcare.
Open filing 0001213900-26-044838 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-16Cruickshank Tim Officer: CFO
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)31,2500.80
25,000

Derived: shares × price per share. Exact value 25000.00.

72,230Direct (D) No
F1, F2
  • F1 These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.
  • F2 Includes 23,333 RSUs which have vested as per the Form 4 filed on October 3, 2025.
Open filing 0001213900-26-044841 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-16STROME MARK E Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)750,0000.80
600,000

Derived: shares × price per share. Exact value 600000.00.

3,650,000Indirect (I) See FootnoteNo
F1, F2
  • F1 These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.
  • F2 The reported securities are held directly by Strome Mezzanine Fund II, LP, Mark E. Strome Living Trust and Strome Dynasty, LLC. Mr. Strome has the authority to vote and dispose of the reported securities held by each of these entities. Mr. Strome disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that Mr. Strome is a beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Open filing 0001213900-26-044832 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-16Vajdic Branislav Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)31,2500.80
25,000

Derived: shares × price per share. Exact value 25000.00.

909,914Direct (D) No
F1
  • F1 These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.
Open filing 0001213900-26-044837 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-16Ferrari Richard Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)62,5000.80
50,000

Derived: shares × price per share. Exact value 50000.00.

291,636Direct (D) No
F1
  • F1 These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.
Open filing 0001213900-26-044835 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-16ENO Robert Paul Officer: President
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)12,5000.80
10,000

Derived: shares × price per share. Exact value 10000.00.

36,742Direct (D) No
F1, F2
  • F1 These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.
  • F2 Includes 23,333 RSUs which have vested as per the Form 4 filed on October 2, 2025.
Open filing 0001213900-26-044834 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-16Ortigas-Wedekind Marga Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)25,0000.80
20,000

Derived: shares × price per share. Exact value 20000.00.

137,293Direct (D) No
F1
  • F1 These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.
Open filing 0001213900-26-044833 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-16Elfrink Willem Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)187,5000.80
150,000

Derived: shares × price per share. Exact value 150000.00.

538,667Direct (D) No
F1
  • F1 These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.
Open filing 0001213900-26-044840 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-03-23JAFF MICHAEL R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)20,6890—95,809Direct (D) No
F1
  • F1 These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the Special RSU), one half of the total number of shares of common stock (Shares) subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.
Open filing 0001213900-26-033041 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-03-23Vajdic Branislav Director · Officer: President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock (right to buy) — underlying Common Stock (61,932) — exercise price 1.45
Acquired (A)61,9320—61,932Direct (D) No
F1
  • F1 Granted options on February 9, 2026 (the Special Option), one half of the total number of shares of common stock (the Shares) subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.
Open filing 0001213900-26-033038 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-03-23de Urioste George Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock (right to buy) — underlying Common Stock (51,724) — exercise price 1.43
Acquired (A)51,7240—51,724Direct (D) No
F1
  • F1 Granted options on February 9, 2026 (the Special Option), one half of the total number of shares of common stock (the Shares) subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.
Open filing 0001213900-26-033025 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-03-23ENO Robert Paul Officer: President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock (right to buy) — underlying Common Stock (55,172) — exercise price 1.45
Acquired (A)55,1720—55,172Direct (D) No
F1
  • F1 Granted options on February 9, 2026 (the Special Option), one half of the total number of shares of common stock (the Shares) subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.
Open filing 0001213900-26-033021 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-03-23Ortigas-Wedekind Marga Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock(right to buy) — underlying Common Stock (44,827) — exercise price 1.43
Acquired (A)44,8270—44,827Direct (D) No
F1
  • F1 Granted options on February 9, 2026 (the Special Option), one half of the total number of shares of common stock (the Shares) subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.
Open filing 0001213900-26-033048 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-03-23Cruickshank Tim Officer: CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock (right to buy) — underlying Common Stock (53,104) — exercise price 1.45
Acquired (A)53,1040—53,104Direct (D) No
F1
  • F1 Granted options on February 9, 2026 (the Special Option), one half of the total number of shares of common stock (the Shares) subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.
Open filing 0001213900-26-033034 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-03-23Nelson Kenneth Warwick III Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)17,2410—144,388Direct (D) No
F1
  • F1 These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the Special RSU), one half of the total number of shares of common stock (Shares) subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.
Open filing 0001213900-26-033029 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-03-23STROME MARK E 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock (right to buy) — underlying Common Stock (41,380) — exercise price 1.43
Acquired (A)41,3800—41,380Direct (D) No
F1
  • F1 Granted options on February 9, 2026 (the Special Option), one half of the total number of shares of common stock (the Shares) subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.
Open filing 0001213900-26-033043 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-03-23Ferrari Richard Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)50,0000—229,136Direct (D) No
F1
  • F1 These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the Special RSU), one half of the total number of shares of common stock (Shares) subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.
Open filing 0001213900-26-033045 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-03-23Elfrink Willem Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock (right to buy) — underlying Common Stock (51,724) — exercise price 1.43
Acquired (A)51,7240—51,724Direct (D) No
F1
  • F1 Granted options on February 9, 2026 (the Special Option), one half of the total number of shares of common stock (the Shares) subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.
Open filing 0001213900-26-033031 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-19de Urioste George Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)33,1852.83
93,913.55

Derived: shares × price per share. Exact value 93913.55.

0Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Open filing 0001213900-25-123939 Read from the filing’s XML Dispute this row
2025-12-17 Filed 2025-12-22STROME MARK E 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)250,0003.58
895,000

Derived: shares × price per share. Exact value 895000.00.

2,900,000Indirect (I) See FootnoteNo
F1, F2
  • F1 The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • F2 The reported securities are held directly by Mark E. Strome Living Trust and Strome Dynasty, LLC. Mr. Strome has the authority to vote and dispose of the reported securities held by each of these entities. Mr. Strome disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that Mr. Strome is a beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Open filing 0001213900-25-124693 Read from the filing’s XML Dispute this row
2025-12-17 Filed 2025-12-19de Urioste George Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)23,9613.68
88,176.48

Derived: shares × price per share. Exact value 88176.48.

33,185Direct (D) No
F1, F2
  • F1 The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • F2 These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024.
Open filing 0001213900-25-123939 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–44 of 44

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
VANGUARD CAPITAL MANAGEMENT LLC 2,137,512 SH784,467 dollarsUnchanged Prior quarter: 2,137,512Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
BlackRock, Inc. Partly reported under another manager980,669 SH359,513 dollarsLower by 7,168 Prior quarter: 987,837Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
CORSAIR CAPITAL MANAGEMENT, L.P. 662,500 SH242,873 dollarsLower by 250,000 Prior quarter: 912,500Open filing 0001013594-26-001187 Filed 2026-11-16 Dispute this row
Bleichroeder LP 625,000 SH229,125 dollarsUnchanged Prior quarter: 625,000Open filing 0001420506-26-002662 Filed 2026-11-13 Dispute this row
ARMISTICE CAPITAL, LLC 500,000 SH3,500 dollarsUnchanged Prior quarter: 500,000Open filing 0001315863-26-000784 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager480,465 SH176,161 dollarsHigher by 1,079 Prior quarter: 479,386Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Sigma Planning Corp 387,200 SH141,948 dollarsHigher by 139,500 Prior quarter: 247,700Open filing 0001420506-26-002366 Filed 2026-10-23 Dispute this row
Smith Salley Wealth Management 367,647 SH134,780 dollarsUnchanged Prior quarter: 367,647Open filing 0001062993-26-005703 Filed 2026-11-03 Dispute this row
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 280,161 SH118,816 dollarsHigher by 71,970 Prior quarter: 208,191Open filing 0001423442-26-000004 Filed 2026-11-12 Dispute this row
RITHOLTZ WEALTH MANAGEMENT 280,161 SH102,707 dollarsHigher by 71,970 Prior quarter: 208,191Open filing 0001698218-26-000007 Filed 2026-11-05 Dispute this row
VANGUARD FIDUCIARY TRUST CO 274,818 SH100,858 dollarsUnchanged Prior quarter: 274,818Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Beacon Pointe Advisors, LLC 247,058 SH90,572 dollarsUnchanged Prior quarter: 247,058Open filing 0002085853-26-001405 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager236,248 SH84,126 dollarsLower by 66,506 Prior quarter: 302,754Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
KESTRA PRIVATE WEALTH SERVICES, LLC 170,439 SH62,483 dollarsLower by 3,000 Prior quarter: 173,439Open filing 0001649451-26-000013 Filed 2026-11-06 Dispute this row
STATE STREET CORP Partly reported under another manager125,473 SH45,998 dollarsUnchanged Prior quarter: 125,473Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager101,129 SH37,074 dollarsUnchanged Prior quarter: 101,129Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
Spectrum Asset Management, Inc. (NB/CA) Partly reported under another manager100,400 SH36,807 dollarsUnchanged Prior quarter: 100,400Open filing 0001632078-26-000011 Filed 2026-10-19 Dispute this row
Cannon Financial Strategists, Inc. 92,645 SH33,964 dollarsHigher by 19,857 Prior quarter: 72,788Open filing 0001951757-26-001680 Filed 2026-10-19 Dispute this row
XTX Topco Ltd Partly reported under another manager78,914 SH28,930 dollarsHigher by 24,640 Prior quarter: 54,274Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
HRT FINANCIAL LP 62,333 SH22 dollarsNot in the prior quarter’s filings read Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager57,045 SH20,913 dollarsUnchanged Prior quarter: 57,045Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
STIFEL FINANCIAL CORP Partly reported under another manager51,000 SH18,697 dollarsUnchanged Prior quarter: 51,000Open filing 0000720672-26-000017 Filed 2026-11-12 Dispute this row
ADVISORY RESEARCH INC 50,000 SH18,330 dollarsUnchanged Prior quarter: 50,000Open filing 0000902584-26-000008 Filed 2026-11-12 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager43,875 SH351 dollarsNot in the prior quarter’s filings read Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
RAYMOND JAMES FINANCIAL INC Partly reported under another manager40,210 SH14,741 dollarsLower by 94,224 Prior quarter: 134,434Open filing 0000720005-26-000081 Filed 2026-11-12 Dispute this row
TWO SIGMA SECURITIES, LLC 21,863 SH3,865 dollarsHigher by 10,210 Prior quarter: 11,653Open filing 0000899140-26-001334 Filed 2026-11-16 Dispute this row
CIBC Bancorp USA Inc. Partly reported under another manager20,631 SH7,563 dollarsUnchanged Prior quarter: 20,631Open filing 0001298088-26-000029 Filed 2026-11-13 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager19,717 SH7,228 dollarsHigher by 15,408 Prior quarter: 4,309Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
Virtu Financial LLC Partly reported under another manager17,524 SH0 dollarsNot in the prior quarter’s filings read Open filing 0001533964-26-000015 Filed 2026-11-17 Dispute this row
Clear Street Group Inc. 16,688 SH117 dollarsHigher by 77 Prior quarter: 16,611Open filing 0001881567-26-000006 Filed 2026-11-16 Dispute this row
D'Orazio Associates, Inc. 16,000 SH93 dollarsLower by 48,987 Prior quarter: 64,987Open filing 0001646821-26-000006 Filed 2026-11-04 Dispute this row
TRUIST FINANCIAL CORP Partly reported under another manager15,000 SH5,499 dollarsUnchanged Prior quarter: 15,000Open filing 0000092230-26-000130 Filed 2026-10-30 Dispute this row
Vanguard Global Advisers, LLC 13,308 SH4,884 dollarsUnchanged Prior quarter: 13,308Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row
Farther Finance Advisors, LLC 12,000 SH4,399 dollarsHigher by 6,000 Prior quarter: 6,000Open filing 0001992825-26-000006 Filed 2026-10-08 Dispute this row
J.W. COLE ADVISORS, INC. 11,000 SH4,033 dollarsUnchanged Prior quarter: 11,000Open filing 0001404763-26-000006 Filed 2026-11-05 Dispute this row
COMMONWEALTH EQUITY SERVICES, LLC Partly reported under another manager10,723 SH3,930 dollarsUnchanged Prior quarter: 10,723Open filing 0000312272-26-000024 Filed 2026-11-02 Dispute this row
HB Wealth Management, LLC 10,000 SH3,666 dollarsUnchanged Prior quarter: 10,000Open filing 0001172661-26-004668 Filed 2026-10-23 Dispute this row
WELLS FARGO COMPANY/MN Partly reported under another manager8,500 SH420 dollarsUnchanged Prior quarter: 8,500Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager7,773 SH2,860 dollarsNot in the prior quarter’s filings read Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
HARBOUR INVESTMENTS, INC. 5,750 SH2,108 dollarsLower by 3,000 Prior quarter: 8,750Open filing 0000810121-26-000006 Filed 2026-11-09 Dispute this row
Blue Trust, Inc. 1,928 SH707 dollarsUnchanged Prior quarter: 1,928Open filing 0001856022-26-000005 Filed 2026-10-15 Dispute this row
Larson Financial Group LLC 1,250 SH458 dollarsUnchanged Prior quarter: 1,250Open filing 0001104659-26-123219 Filed 2026-11-05 Dispute this row
NewEdge Advisors, LLC 1,000 SH367 dollarsUnchanged Prior quarter: 1,000Open filing 0001213900-26-119695 Filed 2026-11-13 Dispute this row
OSAIC HOLDINGS, INC. Partly reported under another manager1,000 SH367 dollarsUnchanged Prior quarter: 1,000Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Davidson Kahn Capital Management, LLC 17,333 SH
  • TWO SIGMA INVESTMENTS, LP 12,926 SH
  • Kestra Advisory Services, LLC 10,000 SH
  • BARCLAYS PLC 2,694 SH
  • Integrated Wealth Concepts LLC 1,000 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
STROME MARK E Common Stock, par value $.0001 per share6.83,764,200.0004/16/2026 Filed 2026-08-13SCHEDULE 13D/AAmendment 1Open filing 0001213900-26-089158 Dispute this row
STROME GROUP, INC. Common Stock, par value $.0001 per share6.63,650,000.0004/16/2026 Filed 2026-08-13SCHEDULE 13D/AAmendment 1Open filing 0001213900-26-089158 Dispute this row
STROME INVESTMENT MANAGEMENT LP Common Stock, par value $.0001 per share6.63,650,000.0004/16/2026 Filed 2026-08-13SCHEDULE 13D/AAmendment 1Open filing 0001213900-26-089158 Dispute this row
Strome Mezzanine Fund II, LP Common Stock, par value $.0001 per share6.63,650,000.0004/16/2026 Filed 2026-08-13SCHEDULE 13D/AAmendment 1Open filing 0001213900-26-089158 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,686,506 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,124

Filings made before the SEC required XML are listed, not extracted.

Back to HEARTBEAM, INC.